Belimumab With Rituximab for Primary Membranous Nephropathy
Clinical trial NCT03949855 · RECRUITING
Trial details
- NCT number
- NCT03949855
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-06
- Primary completion
- 2029-03-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.